ctDNA and MRD | 2023 Best of GI Cancer Conference

Описание к видео ctDNA and MRD | 2023 Best of GI Cancer Conference

In this session, Dr Sam Klempner from Massachusetts General Hospital discusses the use of circulating tumor DNA (ctDNA) testing to monitor for minimal residual disease (MRD) in GI cancer.

Комментарии

Информация по комментариям в разработке